Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management.

bleeding immune thrombocytopenia immunology megakaryocytes platelet

Journal

Research and practice in thrombosis and haemostasis
ISSN: 2475-0379
Titre abrégé: Res Pract Thromb Haemost
Pays: United States
ID NLM: 101703775

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 05 09 2022
revised: 06 02 2023
accepted: 13 02 2023
medline: 18 4 2023
entrez: 17 4 2023
pubmed: 18 4 2023
Statut: epublish

Résumé

The inaugural McMaster Immune Thrombocytopenia (ITP) Summit was held virually in 2021. The objectives of the Summit were to recognize the difficulties in establishing the diagnosis of ITP and to understand gaps in current knowledge of ITP mechanisms that might lead to better diagnostic approaches and treatments. The half-day program consisted of virtual educational sessions targeting clinicians and basic scientists. The planning committee chose 8 topics to review that would cover current knowledge and inform future research priorities. In this report, we summarized the presentations delivered at the 2021 McMaster ITP Summit and the discussions. Based on the information presented at the Summit, the following research priorities were identified: 1) investigation of platelet production as a target for ITP treatments; 2) characterization of antigen processing and antigen presentation on platelets; 3) interaction between megakaryocytes and the immune system; 4) the role for ITP gene panels; 5) the need for better methods for platelet antibody testing; 6) the role of prediction models for diagnosis and prognosis; 7) new treatment strategies, including intensification of initial therapy; and 8) personalized treatment algorithms.

Identifiants

pubmed: 37063755
doi: 10.1016/j.rpth.2023.100097
pii: S2475-0379(23)00066-3
pmc: PMC10099320
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100097

Informations de copyright

© 2023 The Authors.

Références

J Lab Clin Med. 1990 May;115(5):636-45
pubmed: 2187937
J Thromb Haemost. 2020 Oct;18(10):2701-2711
pubmed: 32662223
J Thromb Haemost. 2019 May;17(5):787-794
pubmed: 30801909
Clin Immunol. 2017 Apr;177:18-28
pubmed: 26598010
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Blood. 2013 Mar 14;121(11):1976-81
pubmed: 23293082
Blood. 2021 Aug 5;138(5):401-416
pubmed: 33895821
Lancet Haematol. 2016 Oct;3(10):e489-e496
pubmed: 27658982
Blood. 2018 Mar 15;131(11):1172-1182
pubmed: 29295846
Curr Opin Hematol. 2015 Sep;22(5):445-51
pubmed: 26154508
Blood. 2010 Feb 11;115(6):1247-53
pubmed: 20007808
J Clin Med. 2021 Mar 02;10(5):
pubmed: 33801294
Int J Hematol. 2015 Jul;102(1):7-11
pubmed: 25833724
Blood Adv. 2020 Jul 14;4(13):2962-2966
pubmed: 32603421
Blood Adv. 2021 Oct 26;5(20):4256-4264
pubmed: 34516622
N Engl J Med. 2021 Sep 2;385(10):885-895
pubmed: 34469646
Blood Adv. 2019 Dec 10;3(23):3829-3866
pubmed: 31794604
Ann Hematol. 2021 Nov;100(11):2677-2682
pubmed: 34519886
Semin Thromb Hemost. 2015 Jun;41(4):395-404
pubmed: 25793364
N Engl J Med. 2022 Apr 14;386(15):1421-1431
pubmed: 35417637
Blood Adv. 2017 Sep 08;1(20):1773-1785
pubmed: 29296823
J Immunol. 2012 Jul 15;189(2):916-23
pubmed: 22706078
Blood. 2005 Dec 15;106(13):4066-75
pubmed: 16118320
Lancet. 1972 Jan 1;1(7740):6-9
pubmed: 4108861
Blood. 2021 Dec 23;138(25):2607-2620
pubmed: 34293122
Br J Haematol. 2018 Aug;182(3):423-426
pubmed: 29808904
Int J Hematol. 2020 Aug;112(2):159-168
pubmed: 32476083
Hematol Oncol Stem Cell Ther. 2017 Mar;10(1):8-14
pubmed: 28183683
Am J Hematol. 1991 Aug;37(4):258-62
pubmed: 1858783
N Engl J Med. 2021 Nov 4;385(19):1761-1773
pubmed: 34525277
J Cell Biol. 1999 Dec 13;147(6):1299-312
pubmed: 10601342
Blood Adv. 2021 Mar 23;5(6):1617-1626
pubmed: 33710335
J Thromb Haemost. 2012 Apr;10(4):695-7
pubmed: 22332994
Transfus Med Rev. 2020 Oct;34(4):258-269
pubmed: 33046350
Blood Adv. 2017 Nov 28;1(25):2414-2420
pubmed: 29296891
Am J Hematol. 2019 May;94(5):546-553
pubmed: 30784097
Blood. 2010 Apr 8;115(14):2755-62
pubmed: 20130241
Br J Haematol. 2021 Nov;195(3):365-370
pubmed: 34075578
Blood. 2014 Jun 19;123(25):3906-8
pubmed: 24802773
Blood. 2022 Mar 10;139(10):1564-1574
pubmed: 34587251
Clin Pediatr (Phila). 2011 Mar;50(3):225-30
pubmed: 21098529
Am J Hematol. 2021 May 1;96(5):534-537
pubmed: 33606296
Am J Anat. 1976 Feb;145(2):183-205
pubmed: 1258805
Blood Adv. 2020 Jan 14;4(1):9-18
pubmed: 31891657
Br J Haematol. 2021 Jul;194(2):439-443
pubmed: 34109621
Blood Adv. 2019 Nov 26;3(22):3780-3817
pubmed: 31770441
Vox Sang. 2020 May;115(4):323-333
pubmed: 32080872
Br J Haematol. 2021 Dec;195(5):703-705
pubmed: 34467525
Nat Commun. 2012 May 22;3:852
pubmed: 22617292

Auteurs

Syed Mahamad (S)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Dimpy Modi (D)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Hanny Al-Samkari (H)

Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Adam Cuker (A)

Department of Medicine and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Jenny M Despotovic (JM)

Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine, Houston, Texas, USA.

Joseph E Italiano (JE)

Department of Surgery, Vascular Biology Program, Boston Children's Hospital, Boston, Massachusetts, USA.

Michele P Lambert (MP)

Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Eun-Ju Lee (EJ)

Hematology/Oncology Department, Weill Cornell Medical College, New York, New York, USA.

Matthew T Rondina (MT)

Department of Internal Medicine & The Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.
Department of Internal Medicine, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah, USA.
University of Utah, Department of Pathology, Salt Lake City, Utah, USA.

Michelle Sholzberg (M)

Department of Medicine, and Laboratory Medicine and Pathobiology, St. Michael's Hospital, Toronto, Ontario, Canada.
Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada.

Caroline Kruse (C)

Platelet Disorder Support Association, Cleveland, Ohio, USA.

Mark Larché (M)

Division of Clinical Immunology & Allergy, and Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Firestone Institute for Respiratory Health, McMaster University, Hamilton, Ontario, Canada.

Ishac Nazy (I)

Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Matthew S Miller (MS)

Department of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute for Infectious Disease Research, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.

Donald M Arnold (DM)

Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Classifications MeSH